On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, to discuss her many roles within the Department of Inspections, Appeals, & Licensing (DIAL), as well as the timeline for the new Board of Pharmacy rules pursuant to Governor Reynolds’ Executive Order #10 and HF 555. Anne Schlepphorst serves as the Executive Director of the Iowa Board of Pharmacy, Interim Executive Director of the Iowa Board of Nursing, and Monitoring Bureau Chief. In addition to serving the Boards of Pharmacy and Nursing, Anne truly enjoys spending time working with staff to provide some of the best professional health programming in the country for health professionals struggling with mental health, substance abuse, and/or health-related impairments. Anne has worked with the boards for the past six years and was most recently the Chief Investigator for the Iowa Boards of Pharmacy and Medicine. When not working, Anne and her husband spend most of their time at the baseball field, hockey rink, wrestling mat, or football field watching their 10- and 14-year-old boys. Resources from today’s episode: Published August 7: Iowa Administrative Bulletin: Regulatory Analysis – 481 Iowa Administrative Code Chapters 550-557 (new Iowa Board of Pharmacy rules, proposed) IPA’s Iowa Pharmacy Law & Information Resource Center (LIRC) Connect with us on LinkedIn: Kate Gainer Anne Schlepphorst Iowa Pharmacy Association